Metformin Hydrochloride Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Sandoz, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. GNH USA supplies Metformin Hydrochloride Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is a biguanide used in the management of type 2 diabetes mellitus and related disorders. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes. - Polycystic ovary syndrome: improves insulin sensitivity and may help restore regular ovulation.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Upper respiratory tract infection: occasional cold‑like symptoms.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: liver enzyme elevations. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas.

Metformin Hydrochloride requires careful assessment of patient factors and monitoring to minimize risks. - Renal function: evaluate eGFR before initiation and periodically thereafter. - Hepatic disease: avoid in patients with severe liver impairment. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Concomitant medications: review drugs that may affect renal clearance or increase lactic acidosis. - Pregnancy and lactation: assess risk‑benefit ratio before prescribing. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, necessitating vigilance.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Nitrates: combined use may raise risk of lactic acidosis. - Alcohol abuse: enhances lactic acidosis potential.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.